Daniel Chancellor

Principal Analyst, Thought Leadership

Informa Pharma Intelligence


Daniel has a decade of experience as an analyst in the biopharma industry, primarily focusing on the analysis of diseases and the drug markets that serve them. He is currently working as Principal Analyst within the Thought Leadership team at Informa Pharma Intelligence, covering a range of hot topics across the industry, most recently including immuno-oncology, artificial intelligence and M&A. As part of this, Daniel regularly participates in webinars, conferences and other speaking arrangements, and he is featured across leading publications such as Nature Reviews Drug Discovery, Scientific American, Scrip, In Vivo and Vice. Prior to joining Informa, Daniel worked as a medicinal chemist at the UK biotech company Summit Therapeutics and graduated with First Class Honours in Natural Sciences from the University of Bath.

« Back